Breast cancer antigens. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Breast Cell Line, Tumor Tumor Cells, Cultured Peritoneum MCF-7 Cells Axilla Mammary Glands, Human Lymph Nodes Cell Line Nipples Neoplastic Stem Cells T-Lymphocytes Epithelial Cells Neoplastic Cells, Circulating

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases38

Breast Neoplasms Carcinoma, Ductal, Breast Ovarian Neoplasms Neoplasm Metastasis Breast Diseases Neoplasm Invasiveness Prostatic Neoplasms Neoplasms Breast Neoplasms, Male Lung Neoplasms Krukenberg Tumor Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Adenocarcinoma Mammary Neoplasms, Experimental Carcinoma Neoplasms, Hormone-Dependent Lymphatic Metastasis Neoplasm Recurrence, Local Fibrocystic Breast Disease Disease Progression Colonic Neoplasms Bone Neoplasms Cell Transformation, Neoplastic Carcinoma, Ductal Stomach Neoplasms Carcinoma in Situ Neoplasms, Second Primary Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Pancreatic Neoplasms Fibroadenoma Uterine Cervical Neoplasms Neoplastic Cells, Circulating Neovascularization, Pathologic Colorectal Neoplasms Neoplasms, Basal Cell

Chemicals and Drugs76

Antigens, Neoplasm CA-125 Antigen Antigens Tumor Markers, Biological Antigens, Tumor-Associated, Carbohydrate Carcinoembryonic Antigen Mucin-1 Receptors, Estrogen Antigens, Bacterial Receptor, erbB-2 Tamoxifen Antibodies, Monoclonal Receptors, Progesterone Neoplasm Proteins Antigens, Surface Cancer Vaccines Dialysis Solutions CA-19-9 Antigen Antigens, Viral Antineoplastic Agents, Hormonal Antibodies, Neoplasm Antineoplastic Agents RNA, Messenger Estrogen Receptor alpha Estrogens BRCA2 Protein Epitopes Antigens, Polyomavirus Transforming Antigens, Protozoan BRCA1 Protein GPI-Linked Proteins Antigens, CD Aromatase Inhibitors Estrogen Antagonists HLA Antigens Prostate-Specific Antigen DNA, Neoplasm Membrane Proteins Antigens, Fungal Ki-67 Antigen Estradiol RNA, Small Interfering Fluorouracil Antigens, Helminth H-2 Antigens Antibodies, Monoclonal, Humanized Cyclophosphamide Estrogen Receptor Modulators Tumor Suppressor Protein p53 Selective Estrogen Receptor Modulators Epirubicin Antigens, Viral, Tumor Proliferating Cell Nuclear Antigen Antigens, CD24 Nitriles HLA-DR Antigens RNA, Neoplasm Tumor Suppressor Proteins Receptors, Antigen, T-Cell Receptor, Epidermal Growth Factor Paclitaxel Histocompatibility Antigens Transcription Factors Anticarcinogenic Agents DNA-Binding Proteins Histocompatibility Antigens Class II Triazoles HLA-A2 Antigen Antigens, CD15 Receptors, Antigen, B-Cell O Antigens Anthracyclines MicroRNAs Nuclear Proteins Antibiotics, Antineoplastic Immunoglobulin G

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Prognosis Neoplasm Staging Mammography Immunohistochemistry Sensitivity and Specificity Early Detection of Cancer Mastectomy Risk Factors Immunoenzyme Techniques Enzyme-Linked Immunosorbent Assay Prospective Studies Chemotherapy, Adjuvant Case-Control Studies Survival Analysis Antineoplastic Combined Chemotherapy Protocols Mammary Neoplasms, Experimental Disease-Free Survival Gene Expression Profiling Breast Self-Examination Risk Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Survival Rate Blotting, Western Retrospective Studies Risk Assessment Odds Ratio Mastectomy, Segmental ROC Curve Treatment Outcome Incidence Immunotherapy Xenograft Model Antitumor Assays Cohort Studies Neoplasm Transplantation Multivariate Analysis Peritoneal Dialysis Transplantation, Heterologous Registries Oligonucleotide Array Sequence Analysis Transfection Polymerase Chain Reaction Ultrasonography, Mammary Predictive Value of Tests Kaplan-Meier Estimate Tissue Array Analysis SEER Program Logistic Models Tumor Burden Questionnaires Combined Modality Therapy Reproducibility of Results Breast Implants Mass Screening Peritoneal Dialysis, Continuous Ambulatory Neoplasm Grading Flow Cytometry Radiotherapy, Adjuvant Fluorescent Antibody Technique Confidence Intervals Mammaplasty Clinical Trials as Topic Neoadjuvant Therapy Proportional Hazards Models Drug Screening Assays, Antitumor Genetic Testing Biopsy, Needle Drug Administration Schedule Molecular Targeted Therapy Radiotherapy Sentinel Lymph Node Biopsy Estrogen Replacement Therapy Gene Knockdown Techniques Lymph Node Excision

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes45

Gene Expression Regulation, Neoplastic Sensitivity and Specificity Genes, BRCA1 Postmenopause Genetic Predisposition to Disease Breast Feeding Premenopause Drug Resistance, Neoplasm Cell Proliferation Risk Menopause Genes, BRCA2 Time Factors Mutation Odds Ratio Genes, erbB-2 Signal Transduction Amino Acid Sequence Apoptosis Cell Division Cell Movement Genotype Transfection Base Sequence Down-Regulation Polymorphism, Genetic Germ-Line Mutation Promoter Regions, Genetic DNA Methylation Cell Cycle Phenotype Cell Growth Processes Gene Expression Dose-Response Relationship, Drug Gene Amplification Up-Regulation RNA Interference Cell Survival Parity Phosphorylation Gene Silencing Alleles Genes, Tumor Suppressor Genes, Neoplasm Antibody Specificity

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science8

Molecular Sequence Data Survival Rate Incidence Amino Acid Sequence Registries Base Sequence SEER Program Questionnaires

Named Groups2

Survivors European Continental Ancestry Group

Health Care32

Sensitivity and Specificity Risk Factors Prospective Studies Case-Control Studies Survival Analysis Disease-Free Survival Risk Follow-Up Studies Survival Rate Age Factors Retrospective Studies Risk Assessment Odds Ratio ROC Curve Treatment Outcome Incidence Cohort Studies Multivariate Analysis Registries Predictive Value of Tests Kaplan-Meier Estimate SEER Program Logistic Models Questionnaires Reproducibility of Results Mass Screening Peritoneal Dialysis, Continuous Ambulatory Confidence Intervals Clinical Trials as Topic Parity Proportional Hazards Models Genetic Testing

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Antigens, Neoplasm CA-125 Antigen Breast Breast Neoplasms Antigens Tumor Markers, Biological Antigens, Tumor-Associated, Carbohydrate Carcinoma, Ductal, Breast Ovarian Neoplasms Carcinoembryonic Antigen Mucin-1 Receptors, Estrogen Cell Line, Tumor Neoplasm Metastasis Prognosis Antigens, Bacterial Breast Diseases Receptor, erbB-2 Tamoxifen Antibodies, Monoclonal Receptors, Progesterone Gene Expression Regulation, Neoplastic Neoplasm Staging Mammography Neoplasm Proteins Antigens, Surface Cancer Vaccines Neoplasm Invasiveness Prostatic Neoplasms Dialysis Solutions CA-19-9 Antigen Neoplasms Tumor Cells, Cultured Immunohistochemistry Antigens, Viral Breast Neoplasms, Male Sensitivity and Specificity Antineoplastic Agents, Hormonal Peritoneum Early Detection of Cancer Lung Neoplasms Mastectomy Antibodies, Neoplasm Krukenberg Tumor Risk Factors Immunoenzyme Techniques Antineoplastic Agents Enzyme-Linked Immunosorbent Assay Genes, BRCA1 RNA, Messenger Prospective Studies Postmenopause Chemotherapy, Adjuvant Carcinoma, Lobular Mice, Nude Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease MCF-7 Cells Case-Control Studies Adenocarcinoma Survival Analysis Breast Feeding Antineoplastic Combined Chemotherapy Protocols Molecular Sequence Data Premenopause Drug Resistance, Neoplasm Estrogen Receptor alpha Cell Proliferation Estrogens Mammary Neoplasms, Experimental Carcinoma Disease-Free Survival Gene Expression Profiling Neoplasms, Hormone-Dependent Breast Self-Examination Lymphatic Metastasis Risk Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Neoplasm Recurrence, Local Survival Rate Menopause BRCA2 Protein Epitopes Antigens, Polyomavirus Transforming Antigens, Protozoan BRCA1 Protein Genes, BRCA2 GPI-Linked Proteins Antigens, CD Blotting, Western Fibrocystic Breast Disease Age Factors Retrospective Studies Risk Assessment Disease Progression Aromatase Inhibitors Estrogen Antagonists Survivors Time Factors

No FAQ available that match "breast cancer antigens"